@countZZero @frankp
Because I researched this for an institutional client I will share knowledge.
Answer: There's no correlation. EAU's remain in place along with the data tracking of these products. EAUs generally have 1 of 3 outcomes: they are studied further, they are granted permanent Authorization Use OR they are withdrawn as a treatment option due to lack of efficacy.
In December, monoclonal antibody drugs had EAU withdrawn authorized because they're not effective against COVID-19.
@Bliss @countZZero Superb info - thank you!